|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-1-4020-5955-1 |
003 |
DE-He213 |
005 |
20220118013740.0 |
007 |
cr nn 008mamaa |
008 |
100301s2007 ne | s |||| 0|eng d |
020 |
|
|
|a 9781402059551
|9 978-1-4020-5955-1
|
024 |
7 |
|
|a 10.1007/1-4020-5955-8
|2 doi
|
050 |
|
4 |
|a R850.A1-854
|
050 |
|
4 |
|a QH315-320
|
072 |
|
7 |
|a MBGR
|2 bicssc
|
072 |
|
7 |
|a SCI049000
|2 bisacsh
|
072 |
|
7 |
|a MBGR
|2 thema
|
082 |
0 |
4 |
|a 610.72
|2 23
|
245 |
1 |
0 |
|a Therapeutic Neovascularization - Quo vadis?
|h [electronic resource] /
|c edited by Elisabeth Deindl, Christian Kupatt.
|
250 |
|
|
|a 1st ed. 2007.
|
264 |
|
1 |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2007.
|
300 |
|
|
|a X, 262 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease -- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis -- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction -- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword -- Pampering and Priming the Heart -- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization -- Integrative Pro-angiogenic Activation: HIF-? -- The Maturation of Vessels - A Limitation to Forced Neovascularization? -- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads -- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis -- The Biology of Embryonic and Adult Endothelial Progenitor Cells -- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin -- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.
|
650 |
|
0 |
|a Medicine-Research.
|
650 |
|
0 |
|a Biology-Research.
|
650 |
|
0 |
|a Cardiology.
|
650 |
|
0 |
|a Clinical biochemistry.
|
650 |
|
0 |
|a Cancer.
|
650 |
1 |
4 |
|a Biomedical Research.
|
650 |
2 |
4 |
|a Cardiology.
|
650 |
2 |
4 |
|a Medical Biochemistry.
|
650 |
2 |
4 |
|a Cancer Biology.
|
700 |
1 |
|
|a Deindl, Elisabeth.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Kupatt, Christian.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9789048174881
|
776 |
0 |
8 |
|i Printed edition:
|z 9789048112951
|
776 |
0 |
8 |
|i Printed edition:
|z 9781402059544
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/1-4020-5955-8
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SBL
|
912 |
|
|
|a ZDB-2-SXB
|
950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|